Exit
COVID-19 pandemic has threatened millions of lives worldwide. We would like to learn about the way it has changed our pediatric rheumatology practice. Please take five minutes to complete the below survey.

Question Title

* 1. What is your age?

Question Title

* 2. What is your gender?

Question Title

* 3. Which setting do you practice in?

Question Title

* 4. Which country do you practice in?

Question Title

* 5. Years in pediatric rheumatology practice:

Question Title

* 6. Do you prescribe any of the following drugs less often in your current practice because of the COVID-19 pandemic?

Question Title

* 7. Which biologic drugs do you hesitate most in initiating during the COVID-19 pandemic?

Question Title

* 8. Which non-biologic/conventional synthetic disease modifying anti-rheumatic drugs (DMARDs) do you hesitate most in initiating during the COVID-19 pandemic?

Question Title

* 9. If your patient contracted COVID-19, how was the underlying rheumatic disease affected?

Question Title

* 10. Do you modify anti-rheumatic treatment if your patient has COVID-19?

Question Title

* 11. How do you modify biologic treatment if your patient has COVID-19?

Question Title

* 12. Select the adjustments made in your clinical practice after 2.5 years of COVID-19 pandemic:

Question Title

* 13. Which percentage of your clinical practice is currently based on telemedicine tools?

Question Title

* 14. There are still delays in the diagnosis or treatment of pediatric rheumatic diseases due to the COVID-19 pandemic.

Question Title

* 15. Our clinical practice is returning to routine, as prior to the pandemic.

Question Title

* 16. The vaccination policies have decreased the impact of COVID-19 on pediatric rheumatology practice.

Question Title

* 17. Vaccines against COVID-19 in childhood will reduce the prevalence of multisystem inflammatory syndrome in children (MIS-C)/pediatric inflammatory multisystem syndrome (PIMS).

Question Title

* 18. Do you contribute to the management of MIS-C/PIMS patients?